NDC 0169-4501

WEGOVY

Semaglutide

WEGOVY is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Novo Nordisk. The primary component is Semaglutide.

• Product ID: 0169-4501_424c481d-df27-4faa-ae93-ebe4460fd77d
• NDC: 0169-4501
• Product Type: Human Prescription Drug
• Proprietary Name: WEGOVY
• Generic Name: Semaglutide
• Dosage Form: Injection, Solution
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2021-06-05
• Marketing Category: NDA /
• Application Number: NDA215256
• Labeler Name: Novo Nordisk
• Substance Name: SEMAGLUTIDE
• Active Ingredient Strength: 1 mg/.5mL
• Pharm Classes: GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0169-4501-14

4 SYRINGE, PLASTIC in 1 CARTON (0169-4501-14) > .5 mL in 1 SYRINGE, PLASTIC (0169-4501-01)

• Marketing Start Date: 2021-06-05
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "WEGOVY" or generic name "Semaglutide"

NDC	Brand Name	Generic Name
0169-4501	WEGOVY	semaglutide
0169-4505	WEGOVY	semaglutide
0169-4517	WEGOVY	semaglutide
0169-4524	WEGOVY	semaglutide
0169-4525	WEGOVY	semaglutide
0169-4130	Ozempic	semaglutide
0169-4132	Ozempic	semaglutide
0169-4136	Ozempic	semaglutide
0169-4181	Ozempic	semaglutide
0169-4772	Ozempic	semaglutide
50090-5138	Ozempic	semaglutide
50090-5139	Ozempic	semaglutide